Browse Clinical Trials (783 trials open to new patients)

Abnormal DNA Repair (1 in progress, 1 open to new patients)
Acinar Cell Carcinoma (1 in progress, 1 open to new patients)
Activating Mutations (1 in progress, 1 open to new patients)
Activating RAS Mutation (1 in progress, 1 open to new patients)
Acute Kidney Injury (1 in progress, 1 open to new patients)
Acute Lymphoblastic Leukemia (22 in progress, 22 open to new patients)
Acute Myeloid Leukemia (37 in progress, 37 open to new patients)
Acute Promyelocytic Leukemia (1 in progress, 1 open to new patients)
Adenocarcinoma (1 in progress, 1 open to new patients)
Adenoid Cystic Carcinoma (1 in progress, 1 open to new patients)
Adrenal Cortex Carcinoma (2 in progress, 2 open to new patients)
Adrenal Gland Pheochromocytoma (1 in progress, 1 open to new patients)
Adrenocortical Carcinoma (1 in progress, 1 open to new patients)
Adrenocortical Carcinoma (Part G) (1 in progress, 1 open to new patients)
Aggressive Fibromatosis (1 in progress, 1 open to new patients)
Aggressive NHL (a NHL) (1 in progress, 1 open to new patients)
Aggressive Systemic Mastocytosis (1 in progress, 1 open to new patients)
ALK Fusion Protein Expression (1 in progress, 1 open to new patients)
ALK Gene Mutation (1 in progress, 1 open to new patients)
ALK Gene Rearrangement (3 in progress, 3 open to new patients)
ALK Gene Translocation (2 in progress, 2 open to new patients)
ALK Positive (2 in progress, 2 open to new patients)
ALK-positive Advanced NSCLC (1 in progress, 1 open to new patients)
Anal Basaloid Carcinoma (1 in progress, 1 open to new patients)
Anal Canal Cloacogenic Carcinoma (1 in progress, 1 open to new patients)
Anal Canal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Anal Canal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Anal Cancer (5 in progress, 5 open to new patients)
Anal Intraepithelial Neoplasia (1 in progress, 1 open to new patients)
Anemia (2 in progress, 2 open to new patients)
Angiosarcoma (1 in progress, 1 open to new patients)
Antibiotic Allergy (1 in progress, 1 open to new patients)
Antibiotics (1 in progress, 1 open to new patients)
Apocrine Neoplasm (1 in progress, 1 open to new patients)
Appendix Mucinous Adenocarcinoma (1 in progress, 1 open to new patients)
ARAF Gene Mutation (1 in progress, 1 open to new patients)
Astrocytoma (27 in progress, 27 open to new patients)
ATM Gene Mutation (1 in progress, 1 open to new patients)
Atypical Teratoid Rhabdoid Tumor (2 in progress, 2 open to new patients)
Autoimmune Disease (1 in progress, 1 open to new patients)
B Cells--Tumors (1 in progress, 1 open to new patients)
Barrett's Esophagus (1 in progress, 1 open to new patients)
Basal Cell Carcinoma (4 in progress, 4 open to new patients)
Basal Cell Nevus Syndrome (1 in progress, 1 open to new patients)
BCR-ABL1 Fusion Protein Expression (1 in progress, 1 open to new patients)
BCR/ABL1 Fusion Protein Negative (1 in progress, 1 open to new patients)
Biliary Tract Cancer (6 in progress, 6 open to new patients)
Bladder Cancer (31 in progress, 31 open to new patients)
Bladder Small Cell Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Blood Clot (1 in progress, 1 open to new patients)
Bone Cancer (4 in progress, 4 open to new patients)
BRAF Gene Mutation (2 in progress, 2 open to new patients)
BRAF NP_004324.2:p.V600X (2 in progress, 2 open to new patients)
BRAF V600 Wild Type (1 in progress, 1 open to new patients)
BRAF V600E Mutation Present (1 in progress, 1 open to new patients)
BRAF V600K Mutation Present (1 in progress, 1 open to new patients)
Brain and Central Nervous System Tumor (2 in progress, 2 open to new patients)
Brain Metastases (4 in progress, 4 open to new patients)
Brain Tumor (13 in progress, 13 open to new patients)
BRCA 1 Gene Mutation (5 in progress, 5 open to new patients)
BRCA 2 Gene Mutation (5 in progress, 5 open to new patients)
Breast Cancer (86 in progress, 86 open to new patients)
Breast Screening (1 in progress, 1 open to new patients)
Breast Secretory Carcinoma (1 in progress, 1 open to new patients)
Breast Tumor (1 in progress, 1 open to new patients)
BRIP1 Gene Mutation (1 in progress, 1 open to new patients)
Bronchial Neoplasms (1 in progress, 1 open to new patients)
c-MET Gene Amplification (1 in progress, 1 open to new patients)
Cancer, General (38 in progress, 38 open to new patients)
Cancer, Metastatic (1 in progress, 1 open to new patients)
Cancer Prevention (1 in progress, 1 open to new patients)
Cancer Screening (1 in progress, 1 open to new patients)
Carcinoid Tumor (2 in progress, 2 open to new patients)
Carcinoma Breast (1 in progress, 1 open to new patients)
Carcinoma, Bronchogenic (1 in progress, 1 open to new patients)
Carcinoma, Ductal, Breast (1 in progress, 1 open to new patients)
Carcinoma, Intraductal, Noninfiltrating (1 in progress, 1 open to new patients)
Cardiotoxicity (1 in progress, 1 open to new patients)
Cardiovascular Complication (1 in progress, 1 open to new patients)
Cardiovascular Disease (1 in progress, 1 open to new patients)
Castration Levels of Testosterone (1 in progress, 1 open to new patients)
CD19 Positive (1 in progress, 1 open to new patients)
CD20 Negative (1 in progress, 1 open to new patients)
CD20 Positive (1 in progress, 1 open to new patients)
CD22 Positive (2 in progress, 2 open to new patients)
Central Nervous System Embryonal Tumor (1 in progress, 1 open to new patients)
Central Nervous System Neoplasm (14 in progress, 14 open to new patients)
Cervical Adenosquamous Carcinoma (4 in progress, 4 open to new patients)
Cervical Cancer (15 in progress, 15 open to new patients)
Cervical Clear Cell Adenocarcinoma (1 in progress, 1 open to new patients)
CHEK2 Gene Mutation (1 in progress, 1 open to new patients)
Chemoembolization, Therapeutic (1 in progress, 1 open to new patients)
Chest Wall Disease (1 in progress, 1 open to new patients)
Cholangiocarcinoma (11 in progress, 11 open to new patients)
Chordoma (2 in progress, 2 open to new patients)
Choriocarcinoma (2 in progress, 2 open to new patients)
Chronic Lymphocytic Leukemia (12 in progress, 12 open to new patients)
Cirrhosis (2 in progress, 2 open to new patients)
CNS Malignancies (1 in progress, 1 open to new patients)
CNS Tumor (2 in progress, 2 open to new patients)
Colon Cancer (10 in progress, 10 open to new patients)
Colorectal Cancer (49 in progress, 49 open to new patients)
Colorectal Tumor (1 in progress, 1 open to new patients)
Complete Response (1 in progress, 1 open to new patients)
Congenital Mesoblastic Nephroma (3 in progress, 3 open to new patients)
Crohn's Disease (1 in progress, 1 open to new patients)
Cutaneous Malignancy (1 in progress, 1 open to new patients)
Cutaneous T-Cell Lymphoma (2 in progress, 2 open to new patients)
Cytopenia (1 in progress, 1 open to new patients)
De Novo Myelodysplastic Syndrome (1 in progress, 1 open to new patients)
Decision Support Systems, Clinical (1 in progress, 1 open to new patients)
Deep Vein Thrombosis (1 in progress, 1 open to new patients)
Deleterious ATM Gene Mutation (1 in progress, 1 open to new patients)
Deleterious RAD51C Gene Mutation (1 in progress, 1 open to new patients)
Deleterious RAD51D Gene Mutation (1 in progress, 1 open to new patients)
Depression (1 in progress, 1 open to new patients)
Desmoid Tumor (1 in progress, 1 open to new patients)
Desmoid-Type Fibromatosis (2 in progress, 2 open to new patients)
Differentiated Thyroid Gland Carcinoma (1 in progress, 1 open to new patients)
Digestive System Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Disorders of the Immune System (1 in progress, 1 open to new patients)
DNA Repair Disorder (1 in progress, 1 open to new patients)
Down Syndrome (1 in progress, 1 open to new patients)
Dyspnea (1 in progress, 1 open to new patients)
EGFR Activating Mutation (2 in progress, 2 open to new patients)
EGFR Exon 19 Deletion Mutation (4 in progress, 4 open to new patients)
EGFR Exon 20 Insertion Mutation (2 in progress, 2 open to new patients)
EGFR Gene Amplification (1 in progress, 1 open to new patients)
EGFR Gene Mutation (1 in progress, 1 open to new patients)
EGFR NP_005219.2:p.G719X (2 in progress, 2 open to new patients)
EGFR NP_005219.2:p.L858R (4 in progress, 4 open to new patients)
EGFR NP_005219.2:p.L861Q (2 in progress, 2 open to new patients)
EGFR NP_005219.2:p.T790M (2 in progress, 2 open to new patients)
EGFR T790M Mutation Negative (1 in progress, 1 open to new patients)
Elevated Alpha-Fetoprotein (1 in progress, 1 open to new patients)
Endometrial Cancer (16 in progress, 16 open to new patients)
Ependymal Tumor (1 in progress, 1 open to new patients)
Ependymoma (10 in progress, 10 open to new patients)
Epithelioid Sarcoma (1 in progress, 1 open to new patients)
Epstein Barr Virus (2 in progress, 2 open to new patients)
ERBB2 Gene Amplification (1 in progress, 1 open to new patients)
Esophageal Cancer (7 in progress, 7 open to new patients)
Esophageal Carcinoma (2 in progress, 2 open to new patients)
Esophageal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Esophageal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Esophagogastric Junction (1 in progress, 1 open to new patients)
Esophagogastric Junction Neoplasm (1 in progress, 1 open to new patients)
Estrogen Receptor Negative (5 in progress, 5 open to new patients)
Estrogen Receptor Positive (1 in progress, 1 open to new patients)
Ewing Sarcoma (13 in progress, 13 open to new patients)
Extensive Stage Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Extragonadal Embryonal Carcinoma (1 in progress, 1 open to new patients)
Eyelid Diseases (1 in progress, 1 open to new patients)
EZH2 Gain of Function (1 in progress, 1 open to new patients)
EZH2 Gene Mutation (1 in progress, 1 open to new patients)
Fallopian Tube Cancer (7 in progress, 7 open to new patients)
Fatigue (2 in progress, 2 open to new patients)
FGFR1 Gene Mutation (1 in progress, 1 open to new patients)
FGFR2 Amplification (1 in progress, 1 open to new patients)
FGFR2 Gene Mutation (2 in progress, 2 open to new patients)
FGFR3 Gene Mutation (1 in progress, 1 open to new patients)
FGFR4 Gene Mutation (1 in progress, 1 open to new patients)
Fibrolamellar Carcinoma (1 in progress, 1 open to new patients)
Fibromyxoid Tumor (1 in progress, 1 open to new patients)
Fibrosarcoma (1 in progress, 1 open to new patients)
FIGO Stage III-IV (1 in progress, 1 open to new patients)
Gallbladder Cancer (1 in progress, 1 open to new patients)
Gallbladder Carcinoma (1 in progress, 1 open to new patients)
Ganglioneuroblastoma (3 in progress, 3 open to new patients)
Gastric Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Gastric Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Gastro-esophageal Junction (GEJ) Cancer (1 in progress, 1 open to new patients)
Gastroesophageal Junction Adenocarcinoma (3 in progress, 3 open to new patients)
Gastrointestinal Cancer (1 in progress, 1 open to new patients)
Gastrointestinal Cancer Metastatic (1 in progress, 1 open to new patients)
Gastrointestinal Neoplasms (1 in progress, 1 open to new patients)
Gastrointestinal Stromal Tumor (6 in progress, 6 open to new patients)
Genitourinary Cancer (1 in progress, 1 open to new patients)
Germ Cell Tumor (11 in progress, 11 open to new patients)
Gestational Trophoblastic Tumor (1 in progress, 1 open to new patients)
Giant Cell Carcinoma (1 in progress, 1 open to new patients)
Giant Cell Tumors (1 in progress, 1 open to new patients)
Glioblastoma (22 in progress, 22 open to new patients)
Glioma (52 in progress, 52 open to new patients)
Gliosarcoma (2 in progress, 2 open to new patients)
GNA11 Gene Mutation (2 in progress, 2 open to new patients)
GNAQ Gene Mutation (2 in progress, 2 open to new patients)
Graft Versus Host Disease (1 in progress, 1 open to new patients)
Head and Neck Cancer (36 in progress, 36 open to new patients)
Head and Neck Squamous Cell Carcinoma (27 in progress, 27 open to new patients)
Head and Neck Tumor (4 in progress, 4 open to new patients)
Hematologic Cancer (1 in progress, 1 open to new patients)
Hematologic Malignancies (2 in progress, 2 open to new patients)
Hematologic Neoplasms (1 in progress, 1 open to new patients)
Hematological Malignancy (2 in progress, 2 open to new patients)
Hematopoietic and Lymphoid Cell Neoplasm (1 in progress, 1 open to new patients)
Hematopoietic Cell Transplantation (3 in progress, 3 open to new patients)
Hemispheric (1 in progress, 1 open to new patients)
Hepatic Cancer (1 in progress, 1 open to new patients)
Hepatic Carcinoma (1 in progress, 1 open to new patients)
Hepatitis B (1 in progress, 1 open to new patients)
Hepatitis C (2 in progress, 2 open to new patients)
Hepatoblastoma (11 in progress, 11 open to new patients)
Hepatocellular Cancer (2 in progress, 2 open to new patients)
Hepatocellular Carcinoma (25 in progress, 25 open to new patients)
HER2 (23 in progress, 23 open to new patients)
Histiocytic and Dendritic Cell Neoplasm (1 in progress, 1 open to new patients)
Histiocytic Disorders (1 in progress, 1 open to new patients)
Histiocytosis (6 in progress, 6 open to new patients)
HIV/AIDS (12 in progress, 12 open to new patients)
HLA-A*0201 Positive Cells Present (2 in progress, 2 open to new patients)
HNSCC (1 in progress, 1 open to new patients)
Hodgkin's Lymphoma (7 in progress, 7 open to new patients)
HRAS Gene Mutation (2 in progress, 2 open to new patients)
HRAS Mutant Tumor (1 in progress, 1 open to new patients)
Human Papillomavirus (5 in progress, 5 open to new patients)
Hypercalcemia (1 in progress, 1 open to new patients)
Hypopharyngeal Carcinoma (2 in progress, 2 open to new patients)
Hypopharynx Cancer (1 in progress, 1 open to new patients)
IDH1 Gene Mutation (3 in progress, 3 open to new patients)
IDH2 Gene Mutation (4 in progress, 4 open to new patients)
Immunosuppression (1 in progress, 1 open to new patients)
Immunotherapy (20 in progress, 20 open to new patients)
Infantile Fibrosarcoma (1 in progress, 1 open to new patients)
Infection (1 in progress, 1 open to new patients)
Infertility (3 in progress, 3 open to new patients)
Inflammatory Bowel Disease (2 in progress, 2 open to new patients)
Influenza (1 in progress, 1 open to new patients)
Inherited Abnormalities of Platelets (1 in progress, 1 open to new patients)
Inherited Disorders of Metabolism (1 in progress, 1 open to new patients)
INI1-negative Tumors (1 in progress, 1 open to new patients)
Intermediate Grade Lung Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Intestinal Neoplasms (1 in progress, 1 open to new patients)
Intestinal Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Juvenile Xanthogranuloma (1 in progress, 1 open to new patients)
Kaposi's Sarcoma (6 in progress, 6 open to new patients)
Kidney Cancer (33 in progress, 33 open to new patients)
Kidney Disease (1 in progress, 1 open to new patients)
Kidney Transplant (1 in progress, 1 open to new patients)
KRAS Gene Mutation (3 in progress, 3 open to new patients)
KRAS wt Allele (1 in progress, 1 open to new patients)
Langerhans Cell Histiocytosis (11 in progress, 11 open to new patients)
Laryngeal Cancer (3 in progress, 3 open to new patients)
Leiomyosarcoma (1 in progress, 1 open to new patients)
Leukemia (76 in progress, 76 open to new patients)
Lip and Oral Cavity Cancer (2 in progress, 2 open to new patients)
Lip SCC (1 in progress, 1 open to new patients)
Liposarcoma (1 in progress, 1 open to new patients)
Liver Cancer (29 in progress, 29 open to new patients)
Liver Disease (1 in progress, 1 open to new patients)
Liver Metastases (3 in progress, 3 open to new patients)
Liver Transplant (2 in progress, 2 open to new patients)
Locally Advanced Chordoma (1 in progress, 1 open to new patients)
Locally Advanced Malignant Solid Neoplasm (3 in progress, 3 open to new patients)
Locally Advanced Solid Neoplasm (1 in progress, 1 open to new patients)
Loss of BRG1 Protein Expression (1 in progress, 1 open to new patients)
Loss of INI 1 Protein Expression (1 in progress, 1 open to new patients)
Low Grade Lung Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Lung Cancer (106 in progress, 106 open to new patients)
Lung Large Cell Carcinoma (1 in progress, 1 open to new patients)
Lung Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Lung Non-Small Cell Cancer (7 in progress, 7 open to new patients)
Lung Non-Small Cell Carcinoma (7 in progress, 7 open to new patients)
Lung Non-Squamous Non-Small Cell Carcinoma (3 in progress, 3 open to new patients)
Lung Sarcomatoid Carcinoma (1 in progress, 1 open to new patients)
Lung Small Cell Carcinoma (1 in progress, 1 open to new patients)
Lung Tumor (2 in progress, 2 open to new patients)
Lymphadenopathy (1 in progress, 1 open to new patients)
Lymphedema (1 in progress, 1 open to new patients)
Lymphoma (77 in progress, 77 open to new patients)
Lymphoproliferative Disorder (2 in progress, 2 open to new patients)
Lynch Syndrome (1 in progress, 1 open to new patients)
Major Salivary Gland Carcinoma (1 in progress, 1 open to new patients)
Malignancies Multiple (1 in progress, 1 open to new patients)
Malignancies (1 in progress, 1 open to new patients)
Malignant Central Nervous System Neoplasm (2 in progress, 2 open to new patients)
Malignant Neoplasm (20 in progress, 20 open to new patients)
Malignant Neoplastic Disease (1 in progress, 1 open to new patients)
Malignant Neuroendocrine Carcinoma (Diagnosis) (1 in progress, 1 open to new patients)
Malignant Odontogenic Neoplasm (1 in progress, 1 open to new patients)
Malignant Ovarian Brenner Tumor (1 in progress, 1 open to new patients)
Malignant Peripheral Nerve Sheath Tumor (2 in progress, 2 open to new patients)
Malignant Rhabdoid Tumor (1 in progress, 1 open to new patients)
Malignant Solid Neoplasm (23 in progress, 23 open to new patients)
Malignant Testicular Sex Cord-Stromal Tumor (1 in progress, 1 open to new patients)
Malignant Uterine Neoplasm (1 in progress, 1 open to new patients)
Mantle Cell Lymphoma (7 in progress, 7 open to new patients)
MAP2K1 Gene Mutation (1 in progress, 1 open to new patients)
MAPK1 Gene Mutation (1 in progress, 1 open to new patients)
Matched Targeted Therapy (1 in progress, 1 open to new patients)
Medulloblastoma (12 in progress, 12 open to new patients)
Melanoma (45 in progress, 45 open to new patients)
Meningioma (2 in progress, 2 open to new patients)
Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Mesothelin Positive (1 in progress, 1 open to new patients)
Mesothelioma (8 in progress, 8 open to new patients)
Metastasis (1 in progress, 1 open to new patients)
Metastatic Cancer (4 in progress, 4 open to new patients)
Metastatic Chordoma (1 in progress, 1 open to new patients)
Metastatic Lung Non-Small Cell Carcinoma (1 in progress, 1 open to new patients)
Metastatic Malignant Solid Neoplasm (8 in progress, 8 open to new patients)
Metastatic Neoplasm (1 in progress, 1 open to new patients)
Metastatic Thyroid Gland Carcinoma (1 in progress, 1 open to new patients)
Microsatellite Instability (1 in progress, 1 open to new patients)
Microsatellite Stable (1 in progress, 1 open to new patients)
Minimal Residual Disease (1 in progress, 1 open to new patients)
Mismatch Repair Deficiency (1 in progress, 1 open to new patients)
Mismatch Repair Protein Proficient (1 in progress, 1 open to new patients)
MITF Positive (1 in progress, 1 open to new patients)
Mixed Mesodermal (Mullerian) Tumor (1 in progress, 1 open to new patients)
Mixed Oligoastrocytoma (2 in progress, 2 open to new patients)
MMR-deficient Tumors (1 in progress, 1 open to new patients)
Monosomy 7 (1 in progress, 1 open to new patients)
Mucinous Adenocarcinoma (1 in progress, 1 open to new patients)
Mucinous Cystadenocarcinoma (1 in progress, 1 open to new patients)
Multiple Myeloma (19 in progress, 19 open to new patients)
Mycosis Fungoides (1 in progress, 1 open to new patients)
Mycosis Fungoides (MF) (1 in progress, 1 open to new patients)
Myelodysplasia (1 in progress, 1 open to new patients)
Myelodysplastic Syndrome (12 in progress, 12 open to new patients)
Myelofibrosis (2 in progress, 2 open to new patients)
Myeloma (1 in progress, 1 open to new patients)
Myeloproliferative Neoplasms (4 in progress, 4 open to new patients)
Narcotic Use (1 in progress, 1 open to new patients)
Nasal Cavity Adenocarcinoma (1 in progress, 1 open to new patients)
Nasal Cavity Carcinoma (1 in progress, 1 open to new patients)
Nasopharyngeal Cancer (4 in progress, 4 open to new patients)
Nasopharyngeal Papillary Adenocarcinoma (1 in progress, 1 open to new patients)
Nasopharyngeal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Nasopharynx Cancer (1 in progress, 1 open to new patients)
Nausea and Vomiting (1 in progress, 1 open to new patients)
NBN Gene Mutation (1 in progress, 1 open to new patients)
Neoplasm (5 in progress, 5 open to new patients)
Neoplasm Malignant (1 in progress, 1 open to new patients)
Neoplasm Metastasis (2 in progress, 2 open to new patients)
Neoplasm of Bone (1 in progress, 1 open to new patients)
Neoplasm of Lung (1 in progress, 1 open to new patients)
Neoplasms by Site (1 in progress, 1 open to new patients)
Neoplasms, Colorectal (1 in progress, 1 open to new patients)
Neoplasms, Nerve Tissue (1 in progress, 1 open to new patients)
Neoplasms Pancreatic (1 in progress, 1 open to new patients)
Neuroblastoma (24 in progress, 24 open to new patients)
Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Neuroendocrine Neoplasm (2 in progress, 2 open to new patients)
Neuroendocrine Tumor (7 in progress, 7 open to new patients)
Neurofibromatosis Type 1 (3 in progress, 3 open to new patients)
Neuropathy (1 in progress, 1 open to new patients)
Neutropenia (1 in progress, 1 open to new patients)
Newly Diagnosed (1 in progress, 1 open to new patients)
NF1 Gene Mutation (3 in progress, 3 open to new patients)
NMYC Gene Amplification (1 in progress, 1 open to new patients)
Nodule Solitary Pulmonary (1 in progress, 1 open to new patients)
Non Hodgkin Lymphoma (37 in progress, 37 open to new patients)
Non-Small-Cell Lung (1 in progress, 1 open to new patients)
Non-Small Cell Lung Cancer (68 in progress, 68 open to new patients)
Non-urothelial Bladder (1 in progress, 1 open to new patients)
Non-urothelial Upper Tract (1 in progress, 1 open to new patients)
NRAS Gene Mutation (2 in progress, 2 open to new patients)
NRAS wt Allele (1 in progress, 1 open to new patients)
NSCLC, Recurrent (1 in progress, 1 open to new patients)
NSCLC Stage IIIB (1 in progress, 1 open to new patients)
NSCLC, Stage IIIC (1 in progress, 1 open to new patients)
NSCLC, Stage IV (1 in progress, 1 open to new patients)
NTRK1 Fusion Positive (1 in progress, 1 open to new patients)
NTRK2 Fusion Positive (1 in progress, 1 open to new patients)
NTRK3 Fusion Positive (1 in progress, 1 open to new patients)
NY-ESO-1 Positive (1 in progress, 1 open to new patients)
NY-ESO-1 Positive Tumor Cells Present (1 in progress, 1 open to new patients)
Obesity (1 in progress, 1 open to new patients)
Oligodendroglioma (2 in progress, 2 open to new patients)
Oligometastasis (1 in progress, 1 open to new patients)
Oral Cancer (1 in progress, 1 open to new patients)
Oral Cavity Cancer (1 in progress, 1 open to new patients)
Oral Cavity Carcinoma (1 in progress, 1 open to new patients)
Oral Cavity Verrucous Carcinoma (1 in progress, 1 open to new patients)
Oropharyngeal Cancer (1 in progress, 1 open to new patients)
Oropharyngeal (p16-Negative) Carcinoma (2 in progress, 2 open to new patients)
Oropharyngeal Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
Oropharynx Cancer (2 in progress, 2 open to new patients)
Oropharynx Cancer, Metastatic (1 in progress, 1 open to new patients)
Oropharynx Cancer, Recurrent (1 in progress, 1 open to new patients)
Oropharynx Cancer, Stage III (1 in progress, 1 open to new patients)
Osteosarcoma (14 in progress, 14 open to new patients)
Ovarian Cancer (26 in progress, 26 open to new patients)
Ovarian Clear Cell Adenocarcinoma (3 in progress, 3 open to new patients)
Ovarian Embryonal Carcinoma (1 in progress, 1 open to new patients)
Ovarian Mucinous Adenocarcinoma (2 in progress, 2 open to new patients)
Ovarian Seromucinous Carcinoma (2 in progress, 2 open to new patients)
Ovarian Serous Adenocarcinoma (2 in progress, 2 open to new patients)
Ovarian Tumor (1 in progress, 1 open to new patients)
Ovarian Undifferentiated Carcinoma (1 in progress, 1 open to new patients)
p16 Positive Neoplastic Cells Present (1 in progress, 1 open to new patients)
Paget's Disease (1 in progress, 1 open to new patients)
Pain (2 in progress, 2 open to new patients)
PALB2 Gene Mutation (1 in progress, 1 open to new patients)
Pancreatic Acinar Cell Carcinoma (1 in progress, 1 open to new patients)
Pancreatic Cancer (28 in progress, 28 open to new patients)
Pancreatic Diseases (1 in progress, 1 open to new patients)
Pancreatic Ductal Adenocarcinoma (2 in progress, 2 open to new patients)
Pancreatic Neuroendocrine Carcinoma (1 in progress, 1 open to new patients)
Paranasal Sinus Adenocarcinoma (1 in progress, 1 open to new patients)
Paranasal Sinus Carcinoma (1 in progress, 1 open to new patients)
Parathyroid Gland Carcinoma (1 in progress, 1 open to new patients)
Partial Response (1 in progress, 1 open to new patients)
Pathologic Stage I Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage II Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage IIA Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage IIB Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage III Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage IIIA Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
Pathologic Stage IIIB Merkel Cell Carcinoma (1 in progress, 1 open to new patients)
PD-L1 Positive (1 in progress, 1 open to new patients)
PEComa (1 in progress, 1 open to new patients)
Pediatric Cancer (1 in progress, 1 open to new patients)
Pediatric Central Nervous System Tumor (1 in progress, 1 open to new patients)
Penile Cancer (1 in progress, 1 open to new patients)
Peripheral Primitive Neuroectodermal Tumor (6 in progress, 6 open to new patients)
Peritoneal Cancer (6 in progress, 6 open to new patients)
Pharmacokinetics of Fluorouracil Bolus (5-FU) (1 in progress, 1 open to new patients)
Pharmacokinetics of Oxaliplatin (1 in progress, 1 open to new patients)
Pharmacokinetics of Zolbetuximab (1 in progress, 1 open to new patients)
Pheochromocytoma (1 in progress, 1 open to new patients)
Philadelphia Chromosome Positive (2 in progress, 2 open to new patients)
Pituitary Gland Carcinoma (1 in progress, 1 open to new patients)
Plasma Cell Myeloma (4 in progress, 4 open to new patients)
Plasmacytoma (1 in progress, 1 open to new patients)
Plexiform Neurofibroma (1 in progress, 1 open to new patients)
Poorly Differentiated Thyroid Gland Carcinoma (2 in progress, 2 open to new patients)
Positive Lymph Node (1 in progress, 1 open to new patients)
Postmenopausal (2 in progress, 2 open to new patients)
Primary Peritoneal (1 in progress, 1 open to new patients)
Primary Peritoneal Serous Adenocarcinoma (2 in progress, 2 open to new patients)
Progesterone Receptor Negative (5 in progress, 5 open to new patients)
Progesterone Receptor Positive (1 in progress, 1 open to new patients)
Progressive Disease (2 in progress, 2 open to new patients)
Prostate Cancer (75 in progress, 75 open to new patients)
Prostate Neuroendocrine Neoplasm (1 in progress, 1 open to new patients)
Prostate Small Cell Carcinoma (1 in progress, 1 open to new patients)
PSA Level Greater Than 0.03 (1 in progress, 1 open to new patients)
PSA Level Greater Than or Equal to Two (1 in progress, 1 open to new patients)
PSA Progression (3 in progress, 3 open to new patients)
Pseudomyxoma Peritonei (1 in progress, 1 open to new patients)
PTPN11 Gene Mutation (1 in progress, 1 open to new patients)
Pulmonary Disease (1 in progress, 1 open to new patients)
Pulmonary Embolism (1 in progress, 1 open to new patients)
RAD51 Gene Mutation (1 in progress, 1 open to new patients)
Radiation Toxicity (1 in progress, 1 open to new patients)
Rare Disorder (1 in progress, 1 open to new patients)
RB1 Positive (1 in progress, 1 open to new patients)
Rectal Cancer (7 in progress, 7 open to new patients)
Recurrent Tumor (1 in progress, 1 open to new patients)
Refractory Cancer (1 in progress, 1 open to new patients)
Refractory Central Nervous System Neoplasm (12 in progress, 12 open to new patients)
Refractory Central Nervous System Tumor (1 in progress, 1 open to new patients)
Refractory Germ-cell (1 in progress, 1 open to new patients)
Refractory Hepatoblastoma (4 in progress, 4 open to new patients)
Refractory Langerhans Cell Histiocytosis (8 in progress, 8 open to new patients)
Refractory Malignant Solid Neoplasm (18 in progress, 18 open to new patients)
Refractory Neoplasm (1 in progress, 1 open to new patients)
Refractory Neurofibromatosis Type 1 (1 in progress, 1 open to new patients)
Refractory Osteosarcoma (8 in progress, 8 open to new patients)
Refractory Plasma Cell Myeloma (3 in progress, 3 open to new patients)
Refractory Tumor (1 in progress, 1 open to new patients)
Relapsed Central Nervous System Tumor (1 in progress, 1 open to new patients)
Renal Cell Carcinoma (25 in progress, 25 open to new patients)
Renal Medullary Carcinoma (1 in progress, 1 open to new patients)
Renal Pelvis Cancer (2 in progress, 2 open to new patients)
Renal Pelvis Neoplasms (2 in progress, 2 open to new patients)
Resected Mass (1 in progress, 1 open to new patients)
Resistant Cancer (1 in progress, 1 open to new patients)
Respiratory Tract Neoplasms (1 in progress, 1 open to new patients)
Rhabdoid Tumor (12 in progress, 12 open to new patients)
Rhabdomyosarcoma (13 in progress, 13 open to new patients)
Richter's Syndrome (2 in progress, 2 open to new patients)
ROS1 Fusion Positive (1 in progress, 1 open to new patients)
ROS1 Gene Mutation (1 in progress, 1 open to new patients)
ROS1 Gene Translocation (1 in progress, 1 open to new patients)
Salivary Cancer (1 in progress, 1 open to new patients)
Salivary Gland Cancer (2 in progress, 2 open to new patients)
Salivary Gland Neoplasms (1 in progress, 1 open to new patients)
Sarcoma (33 in progress, 33 open to new patients)
Sdh (1 in progress, 1 open to new patients)
Selected Tumors With Rhabdoid Features (1 in progress, 1 open to new patients)
Seminal Vesicle Adenocarcinoma (1 in progress, 1 open to new patients)
Seminoma (2 in progress, 2 open to new patients)
Serous Cystadenocarcinoma (1 in progress, 1 open to new patients)
Sinonasal Carcinoma (1 in progress, 1 open to new patients)
Skin Cancer/Melanoma (47 in progress, 47 open to new patients)
Sleep Disorders (1 in progress, 1 open to new patients)
Small Intestinal Adenocarcinoma (1 in progress, 1 open to new patients)
SMARCA4 Gene Inactivation (1 in progress, 1 open to new patients)
SMARCB1 Gene Inactivation (1 in progress, 1 open to new patients)
SMARCB1 Gene Mutation (1 in progress, 1 open to new patients)
Soft Tissue Sarcoma (16 in progress, 16 open to new patients)
Solid Cancers (1 in progress, 1 open to new patients)
Solid Neoplasm (7 in progress, 7 open to new patients)
Solid Tumor (104 in progress, 104 open to new patients)
Spinal Column Tumor (1 in progress, 1 open to new patients)
Spindle Cell Neoplasm (1 in progress, 1 open to new patients)
Splenomegaly (1 in progress, 1 open to new patients)
Squamous Cell Carcinoma (41 in progress, 41 open to new patients)
Squamous Intraepithelial Lesion (1 in progress, 1 open to new patients)
Squamous Intraepithelial Neoplasia (1 in progress, 1 open to new patients)
Steatohepatitis (1 in progress, 1 open to new patients)
Stomach Cancer (20 in progress, 20 open to new patients)
Stomach Neoplasms (1 in progress, 1 open to new patients)
Stromal Neoplasm (1 in progress, 1 open to new patients)
Surgery (1 in progress, 1 open to new patients)
Surgical Incision (1 in progress, 1 open to new patients)
Surgical Site Infection (1 in progress, 1 open to new patients)
Surgical Wound Infection (1 in progress, 1 open to new patients)
Surgical Wound, Recent (1 in progress, 1 open to new patients)
Synovial Sarcoma (2 in progress, 2 open to new patients)
T Cell Lymphoma (6 in progress, 6 open to new patients)
Teratoma (3 in progress, 3 open to new patients)
Testicular Cancer (1 in progress, 1 open to new patients)
Testicular Tumor (1 in progress, 1 open to new patients)
TFE3 Gene Translocation (1 in progress, 1 open to new patients)
TFEB Gene Translocation (1 in progress, 1 open to new patients)
Thoracic Neoplasms (1 in progress, 1 open to new patients)
Thyroid Cancer (7 in progress, 7 open to new patients)
Thyroid Gland Carcinoma (5 in progress, 5 open to new patients)
Thyroid Gland Follicular Carcinoma (2 in progress, 2 open to new patients)
Thyroid Gland Medullary Carcinoma (1 in progress, 1 open to new patients)
Thyroid Gland Oncocytic Follicular Carcinoma (1 in progress, 1 open to new patients)
Thyroid Gland Papillary Carcinoma (2 in progress, 2 open to new patients)
TP53 wt Allele (1 in progress, 1 open to new patients)
Tracheal Carcinoma (1 in progress, 1 open to new patients)
Transitional Cell Carcinoma (33 in progress, 33 open to new patients)
Treatment-Related Cancer (1 in progress, 1 open to new patients)
Trisomy 21 (1 in progress, 1 open to new patients)
Trisomy 21 Mosaicism (1 in progress, 1 open to new patients)
TSC1 Gene Mutation (2 in progress, 2 open to new patients)
TSC2 Gene Mutation (2 in progress, 2 open to new patients)
Tumors (1 in progress, 1 open to new patients)
Tumor Metastasis (1 in progress, 1 open to new patients)
Tumor Neck (1 in progress, 1 open to new patients)
Tumor Recurrence (1 in progress, 1 open to new patients)
Tumor Types With FGFR2 Gene Fusions (1 in progress, 1 open to new patients)
Unresectable Chordoma (1 in progress, 1 open to new patients)
Unresectable Esophageal Carcinoma (1 in progress, 1 open to new patients)
Unresectable Gallbladder Carcinoma (1 in progress, 1 open to new patients)
Unresectable Malignant Solid Neoplasm (1 in progress, 1 open to new patients)
Unresectable Solid Neoplasm (4 in progress, 4 open to new patients)
Ureter Adenocarcinoma (1 in progress, 1 open to new patients)
Ureter Cancer (2 in progress, 2 open to new patients)
Ureter Small Cell Carcinoma (1 in progress, 1 open to new patients)
Ureteral Neoplasms (2 in progress, 2 open to new patients)
Urethral Adenocarcinoma (1 in progress, 1 open to new patients)
Urethral Cancer (3 in progress, 3 open to new patients)
Urethral Neoplasms (2 in progress, 2 open to new patients)
Urinary Bladder Tumor (3 in progress, 3 open to new patients)
Urologic Neoplasms (2 in progress, 2 open to new patients)
Uterine Cancer (6 in progress, 6 open to new patients)
Uterine Neoplasms (1 in progress, 1 open to new patients)
Vaginal Adenocarcinoma (2 in progress, 2 open to new patients)
Vaginal Adenosquamous Carcinoma (1 in progress, 1 open to new patients)
Vaginal Cancer (2 in progress, 2 open to new patients)
Venous Thromboembolism (1 in progress, 1 open to new patients)
Vulvar Carcinoma (1 in progress, 1 open to new patients)
Waldenstrom Macroglobulinemia (1 in progress, 1 open to new patients)
Wilms Tumor (11 in progress, 11 open to new patients)